[
フレーム]
Please make JavaScript on and see this site.
Back
-
Regulations & Services of PMDA
Information about Approved Products in Japan
-
Information for approved products in Japan
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
-
Regulations and services of PMDA
Information for approved products in Japan
Back
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Reviews and Related Services
Post-marketing Safety Measures
-
Reviews and Related Services
Post-marketing Safety Measures
Regulatory Science/The Science Board/Standard Development
The 46th Science Board Meeting
Press Release
July 26, 2023 from 2pm to 4pm
Agenda / List of Handouts
Agenda
- Activity Report on Subcommittees
- (1) Software as a Medical Device Utilizing AI and Machine Learning
- (2) Cell and Gene Therapy Products Produced in vivo
- Others
List of Handouts
- Document 1 Outline of Report from the Subcommittee on Software as a Medical Device Utilizing AI and Machine Learning
- Document 2 Report from the Subcommittee on Software as a Medical Device Utilizing AI and Machine Learning
- Document 3 Activity Report on the Subcommittee on Cell and Gene Therapy Products Produced in vivo